| Literature DB >> 10866371 |
A Spaltenstein1, M R Almond, W J Bock, D G Cleary, E S Furfine, R J Hazen, W M Kazmierski, F G Salituro, R D Tung, L L Wright.
Abstract
A novel series of HIV protease inhibitors containing cyclic P1/P2 scaffolds has been synthesized and evaluated for biological activity. The trans 3,5-dibenzyl-2-oxo pyrrolidinone ring system resulted in a 50 pM enzyme inhibitor against HIV protease in vitro when combined with an indanolamine derived P'-backbone. This compound also shows comparable activity to currently marketed drugs in the MT-4 cell-based antiviral assay.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10866371
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823